Analysed MIRA PHARMACEUTICALS INC (MIRA:NASDAQ) News Sources
MIRA Pharmaceuticals Announces Acceptance of Peer-Reviewed SKNY-1 Manuscript Highlighting Oral Obesity and Nicotine Addiction Drug Candidate
13-05-2026
yahoo.com
MIRA Pharmaceuticals Secures Worldwide Rights for Ketamir-2, Expanding Global IP Portfolio Across 10 Major Markets Ahead of Phase 2a in CIPN
27-05-2026
yahoo.com
MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy
17-06-2026
yahoo.com
MIRA Pharmaceuticals Reports New Preclinical Data Demonstrating Mira-55's Differentiated Mechanism of Action and Anxiolytic Activity Relative to THC
25-06-2026
yahoo.com
MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction
06-07-2026
yahoo.com
What is the current price of MIRA PHARMACEUTICALS INC (MIRA:NASDAQ)?
The current price of MIRA PHARMACEUTICALS INC (MIRA:NASDAQ) is $0.7701.
MIRA PHARMACEUTICALS INC (MIRA:NASDAQ) absolute price change since previous trading day?
The absolute price change of MIRA PHARMACEUTICALS INC (MIRA:NASDAQ) since the previous trading day is $0.0201.
MIRA PHARMACEUTICALS INC (MIRA:NASDAQ) percentage price change since previous trading day?
The percentage price change of MIRA PHARMACEUTICALS INC (MIRA:NASDAQ) since the previous trading day is 2.68%.
What is the most recent average sentiment score for MIRA PHARMACEUTICALS INC (MIRA:NASDAQ)?
The most recent average sentiment score for MIRA PHARMACEUTICALS INC (MIRA:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for MIRA PHARMACEUTICALS INC (MIRA:NASDAQ)?
The most recent sentiment for MIRA PHARMACEUTICALS INC (MIRA:NASDAQ) is .
SEC-8K** Filing Available For MIRA PHARMACEUTICALS INC (MIRA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.